Literature DB >> 1466798

Peptide-MHC interaction in autoimmunity.

P J Fairchild1, D C Wraith.   

Abstract

Our increased understanding of the molecular basis of autoimmunity owes much to an appreciation of general principles governing peptide-MHC interactions. Such understanding may help resolve long-standing questions concerning autoimmune diseases and aid development of improved therapeutic strategies for their treatment.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1466798     DOI： 10.1016/0952-7915(92)90056-k

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN： 0952-7915            Impact factor:   7.486


  4 in total

Review 1.  Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.

Authors:  P J Fairchild; C J Thorpe; P J Travers; D C Wraith
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

2.  MHC-I peptide binding activity assessed by exchange after cleavage of peptide covalently linked to β2-microglobulin.

Authors:  Mollie M Jurewicz; Richard A Willis; Vasanthi Ramachandiran; John D Altman; Lawrence J Stern
Journal:  Anal Biochem       Date:  2019-06-13       Impact factor: 3.365

3.  Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation.

Authors:  A M Luo; K M Garza; D Hunt; K S Tung
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

4.  HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.

Authors:  E Ulvestad; K Williams; L Bø; B Trapp; J Antel; S Mørk
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.